Skip to main content
Advertisement
Advertisement

PYPD

PYPD logo

PolyPid Ltd. Ordinary Shares

5.27
USD
Sponsored
-0.18
-3.30%
Sep 23, 16:00 UTC -4
Closed
exchange

After-Market

5.43

+0.16
+3.02%

PYPD Earnings Reports

Positive Surprise Ratio

PYPD beat 16 of 25 last estimates.

64%

Next Report

Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
$10.20M
/
$0.05
Implied change from Q2 26 (Revenue/ EPS)
--
/
-114.29%
Implied change from Q3 25 (Revenue/ EPS)
--
/
-113.51%

PolyPid Ltd. Ordinary Shares earnings per share and revenue

On Aug 12, 2026, PYPD reported earnings of -0.35 USD per share (EPS) for Q2 26, beating the estimate of -0.38 USD, resulting in a 9.28% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.33% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of 0.05 USD, with revenue projected to reach 10.20 million USD, implying an decrease of -114.29% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, PolyPid Ltd. Ordinary Shares reported EPS of -$0.35, beating estimates by 9.28%, and revenue of $0.00, 0% as expectations.
The stock price moved up 2.33%, changed from $4.73 before the earnings release to $4.84 the day after.
The next earning report is scheduled for Nov 10, 2026.
Based on 4 analysts, PolyPid Ltd. Ordinary Shares is expected to report EPS of $0.05 and revenue of $10.20M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement